Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
31.05.24
/
50%
€36.00
Target price
31.05.25
€66.15
Performance (%)
43.06%
Price
29.08.24
€51.00
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc. has seen massive gains of 43.06%. This prediction currently runs until 31.05.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 0.990% | 0.990% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Robert W. Baird from $68.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
30.01.24
30.01.24
€62.74
30.01.25
30.01.25
26.23%
29.08.24
29.08.24